32764275|t|Postulated Adjuvant Therapeutic Strategies for COVID-19.
32764275|a|The number of COVID-19 patients is still growing exponentially worldwide due to the high transmissibility of the SARS-CoV-2 virus. Therapeutic agents currently under investigation are antiviral drugs, vaccines, and other adjuvants that could relieve symptoms or improve the healing process. In this review, twelve therapeutic agents that could play a role in prophylaxis or improvement of the COVID-19-associated symptoms (as add-on substances) are discussed. Agents were identified based on their known pharmacologic mechanism of action in viral and/or nonviral fields and are postulated to interact with one or more of the seven known mechanisms associated with the SARS-CoV-2 virus: (i) regulation of the immune system; (ii) virus entrance in the cell; (iii) virus replication; (iv) hyperinflammation; (v) oxidative stress; (vi) thrombosis; and (vii) endotheliitis. Selected agents were immune transfer factor (oligo- and polypeptides from porcine spleen, ultrafiltered at <10 kDa; Imuno TF ), anti-inflammatory natural blend (Uncaria tomentosa, Endopleura uchi and Haematoccocus pluvialis; Miodesin ), zinc, selenium, ascorbic acid, cholecalciferol, ferulic acid, spirulina, N-acetylcysteine, glucosamine sulfate potassium hydrochloride, trans-resveratrol, and maltodextrin-stabilized orthosilicic acid (SiliciuMax ). This review gives the scientific background on the hypothesis that these therapeutic agents can act in synergy in the prevention and improvement of COVID-19-associated symptoms.
32764275	47	55	COVID-19	Disease	MESH:D000086382
32764275	71	79	COVID-19	Disease	MESH:D000086382
32764275	80	88	patients	Species	9606
32764275	170	180	SARS-CoV-2	Species	2697049
32764275	450	458	COVID-19	Disease	MESH:D000086382
32764275	725	735	SARS-CoV-2	Species	2697049
32764275	843	860	hyperinflammation	Disease	
32764275	889	899	thrombosis	Disease	MESH:D013927
32764275	911	924	endotheliitis	Disease	MESH:D005642
32764275	1042	1050	Imuno TF	Chemical	-
32764275	1059	1071	inflammatory	Disease	MESH:D007249
32764275	1087	1104	Uncaria tomentosa	Species	128375
32764275	1106	1121	Endopleura uchi	Species	2321367
32764275	1126	1149	Haematoccocus pluvialis	Species	
32764275	1151	1159	Miodesin	Chemical	-
32764275	1169	1177	selenium	Chemical	MESH:D012643
32764275	1179	1192	ascorbic acid	Chemical	MESH:D001205
32764275	1194	1209	cholecalciferol	Chemical	MESH:D002762
32764275	1211	1223	ferulic acid	Chemical	MESH:C004999
32764275	1236	1252	N-acetylcysteine	Chemical	MESH:D000111
32764275	1254	1297	glucosamine sulfate potassium hydrochloride	Chemical	-
32764275	1299	1316	trans-resveratrol	Chemical	MESH:D000077185
32764275	1322	1345	maltodextrin-stabilized	Chemical	-
32764275	1346	1363	orthosilicic acid	Chemical	-
32764275	1365	1375	SiliciuMax	Chemical	-
32764275	1527	1535	COVID-19	Disease	MESH:D000086382
32764275	Negative_Correlation	MESH:D002762	MESH:D000086382
32764275	Negative_Correlation	MESH:D000077185	MESH:D000086382
32764275	Negative_Correlation	MESH:D000111	MESH:D000086382
32764275	Negative_Correlation	MESH:D001205	MESH:D000086382
32764275	Negative_Correlation	MESH:D012643	MESH:D000086382
32764275	Negative_Correlation	MESH:D000111	MESH:D005642
32764275	Negative_Correlation	MESH:C004999	MESH:D000086382

